CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX)
CUSIP: 230770109
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common stock
- Shares outstanding
- 15,075,924
- Total 13F shares
- 2,446,157
- Share change
- -262,184
- Total reported value
- $5,893,000
- Price per share
- $2.41
- Number of holders
- 15
- Value change
- -$555,959
- Number of buys
- 2
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 230770109?
CUSIP 230770109 identifies CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 230770109:
Top shareholders of CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
4.2%
|
627,200
|
$1,302,000 | — | 30 Jun 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
4.1%
|
622,228
|
$1,291,000 | — | 30 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.5%
|
374,691
|
$778,000 | — | 30 Jun 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
286,655
|
$595,000 | — | 30 Jun 2022 | |
| BERKSHIRE ASSET MANAGEMENT LLC/PA |
13F
|
Company |
1.3%
|
189,048
|
$392,000 | — | 30 Jun 2022 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.2%
|
188,164
|
$390,000 | — | 30 Jun 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.93%
|
140,248
|
$292,000 | — | 30 Jun 2022 | |
| Martin E. Cearnal |
3/4/5
|
Sr VP/Chief Commercial Officer, Director |
—
class O/S missing
|
163,473
|
$277,904 | — | 17 Mar 2022 | |
| Leo Pavliv |
3/4/5
|
SVP and Chief Development Off. |
—
class O/S missing
|
129,618
|
$220,351 | — | 31 May 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.5%
|
74,718
|
$155,000 | — | 30 Jun 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.34%
|
51,502
|
$107,000 | — | 30 Jun 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.29%
|
43,045
|
$89,000 | — | 30 Jun 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.23%
|
34,592
|
$72,000 | — | 30 Jun 2022 | |
| Sterling Financial Planning, Inc. |
13F
|
Company |
0.15%
|
22,031
|
$46,000 | — | 30 Jun 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.12%
|
18,112
|
$38,000 | — | 30 Jun 2022 | |
| Jonathan Griggs |
3/4/5
|
Director |
—
class O/S missing
|
14,803
|
$25,165 | — | 17 Mar 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.07%
|
10,835
|
$22,000 | — | 30 Jun 2022 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.07%
|
10,300
|
$21,000 | — | 30 Jun 2022 | |
| Michael Bonner |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
11,720
|
$19,924 | — | 17 Mar 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.03%
|
4,898
|
$10,000 | — | 30 Jun 2022 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
3,783
|
$8,000 | — | 30 Jun 2022 | |
| Oakworth Capital, Inc. |
13F
|
Company |
0.02%
|
3,052
|
$6,000 | — | 30 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
2,660
|
$6,000 | — | 30 Jun 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
579
|
$1,000 | — | 30 Jun 2022 |
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) as of Q3 2022
As of 30 Sep 2022,
CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,446,157 shares.
The largest 10 holders included
DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, ACADIAN ASSET MANAGEMENT LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP, STATE STREET CORP, and TWO SIGMA ADVISERS, LP.
This page lists
15
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
20
Q3 2022 holders
15
Holder diff
-5
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.